TickerHumSide-by-side comparison
Abbott Laboratories vs Boston Scientific
As of Nov 11, 2026, P/E is 40.6x for Abbott Laboratories vs 19.0x for Boston Scientific; P/S is 3.9x for Abbott Laboratories vs 3.1x for Boston Scientific; revenue growth is 10.0% for Abbott Laboratories vs 8.9% for Boston Scientific; operating margin is 13.8% for Abbott Laboratories vs 18.7% for Boston Scientific.
What stands out
- Boston Scientific is cheaper on earnings: 19.0x P/E vs 40.6x for Abbott Laboratories.
- Abbott Laboratories's shares did better over the past year: -15.2% vs -56.7% for Boston Scientific.
Key metrics
| Metric | ABT | BSX |
|---|---|---|
| Price | $109.29 | $45.13 |
| Market cap | $189.28B | $65.41B |
| P/E | 40.6x (#2) | 19.0x (#1) |
| P/S | 3.9x (#2) | 3.1x (#1) |
| Revenue growth | 10.0% (#1) | 8.9% (#2) |
| Operating margin | 13.8% (#2) | 18.7% (#1) |
| Net margin | 9.7% (#2) | 16.6% (#1) |
| Debt / equity | 0.58 (#2) | 0.43 (#1) |
| 1-year return | -15.2% (#1) | -56.7% (#2) |
| Research score | 48/100 (#2) | 49/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Abbott Laboratories (ABT) — Medical Devices
- Boston Scientific Corporation (BSX) — Medical Devices